➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Dow
Mallinckrodt
Harvard Business School
Colorcon

Last Updated: October 24, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ZOSTER VACCINE RECOMBINANT, ADJUVANTED

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for zoster vaccine recombinant, adjuvanted

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03771157 Serologic Response to a New Recombinant, Adjuvanted Herpes Zoster Vaccine in Patients With Chronic Lymphocytic Leukemia and Waldenström Macroglobulinemia Treated With First-Line BTK Inhibitors Not yet recruiting University of Rochester Early Phase 1 2019-01-01 The primary objective of the study is to assess the capability of a patient with Chronic Lymphocytic Leukemia (CLL) or Waldenström Macroglobulinemia (WM) to generate an immune response to the Shingrix vaccine under first-line BTK inhibitors.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for zoster vaccine recombinant, adjuvanted

Condition Name

Condition Name for zoster vaccine recombinant, adjuvanted
Intervention Trials
Waldenstrom Macroglobulinemia (WM) 1
Chronic Lymphocytic Leukemia (CLL) 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for zoster vaccine recombinant, adjuvanted
Intervention Trials
Waldenstrom Macroglobulinemia 1
Leukemia, Lymphoid 1
Leukemia, Lymphocytic, Chronic, B-Cell 1
Leukemia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for zoster vaccine recombinant, adjuvanted

Clinical Trial Phase

Clinical Trial Phase for zoster vaccine recombinant, adjuvanted
Clinical Trial Phase Trials
Early Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for zoster vaccine recombinant, adjuvanted
Clinical Trial Phase Trials
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for zoster vaccine recombinant, adjuvanted

Sponsor Name

Sponsor Name for zoster vaccine recombinant, adjuvanted
Sponsor Trials
University of Rochester 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for zoster vaccine recombinant, adjuvanted
Sponsor Trials
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Baxter
Dow
AstraZeneca
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.